Molecular Pathways in Hypertensive Renal Damage-Reference-Cited by-同舟云学术

Molecular Pathways in Hypertensive Renal Damage

Published:2018 Issue: Volume: Page:445-463
ISSN:2366-4606
Container-title:Updates in Hypertension and Cardiovascular Protection
language:
Short-container-title:

Author:

Imig John D.,Khan Md. Abdul H.,El-Meanawy Ashraf

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-59918-2_26

Reference125 articles.

1. Schoenborn C (2009) Health characteristics of adults aged 55 years and over: United States, 2004–2007. Natl Health Stat Report 16:1–31

2. U.S. Renal Data System (2009) USRDS 2009 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda

3. Appel LJ (2010) Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 363:918–929

4. Agodoa LY, Appel L, Bakris GL et al (2001) Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 6:2719–2728

5. Tocci G, Volpe M (2011) End-organ protection in patients with hypertension: focus on the role of angiotensin receptor blockers on renal function. Drugs 71:1003–1017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epoxyeicosanoids in Hypertension;Physiological Research;2019-10-21

2. Prediction of Drug Positioning for Quan-Du-Zhong Capsules Against Hypertensive Nephropathy Based on the Robustness of Disease Network;Frontiers in Pharmacology;2019-02-12